BUZZ-Tenaya Therapeutics slides after launching stock offering

Reuters12-12

BUZZ-Tenaya <a href="https://laohu8.com/S/LENZ">Therapeutics</a> slides after launching stock offering

** Drug developer Tenaya Therapeutics' TNYA.O shares slide 12.5% to $1.19 in extended trading

** TNYA unveils public offering of common stock and warrants; size not disclosed

** Leerink Partners and Piper Sandler are joint bookrunning managers for offering

** Separately, TNYA announces data from early trial for experimental gene therapy in rare heart condition

** TNYA has 166.5 million outstanding shares for $233 million market cap, per LSEG data

** All eight brokerages covering the stock rate it "buy" or higher; median PT $5 - data compiled by LSEG

** As of last close, TNYA stock down 4.9% YTD

(Reporting by Arasu Kannagi Basil in Bengaluru)

((ArasuKannagi.Basil@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2590544071?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-12-12 06:25","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2590544071","market":"fut","top_or_hot":-1,"title":"BUZZ-Tenaya Therapeutics slides after launching stock offering","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BUZZ-Tenaya <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> slides after launching stock offering</title></head><body><p>** Drug developer Tenaya Therapeutics' <span>TNYA.O</span> shares slide 12.5% to $1.19 in extended trading</p><p>** TNYA unveils public offering of common stock and warrants; size not disclosed</p><p>** Leerink Partners and Piper Sandler are joint bookrunning managers for offering</p><p> ** Separately, TNYA announces data from early trial for experimental gene therapy in rare heart condition</p><p>** TNYA has 166.5 million outstanding shares for $233 million market cap, per LSEG data</p><p>** All eight brokerages covering the stock rate it \"buy\" or higher; median PT $5 - data compiled by LSEG</p><p>** As of last close, TNYA stock down 4.9% YTD</p><p> (Reporting by Arasu Kannagi Basil in Bengaluru)</p><p> ((ArasuKannagi.Basil@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BUZZ-Tenaya Therapeutics slides after launching stock offering</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBUZZ-Tenaya Therapeutics slides after launching stock offering\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-12-12 06:25</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BUZZ-Tenaya <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> slides after launching stock offering</title></head><body><p>** Drug developer Tenaya Therapeutics' <span>TNYA.O</span> shares slide 12.5% to $1.19 in extended trading</p><p>** TNYA unveils public offering of common stock and warrants; size not disclosed</p><p>** Leerink Partners and Piper Sandler are joint bookrunning managers for offering</p><p> ** Separately, TNYA announces data from early trial for experimental gene therapy in rare heart condition</p><p>** TNYA has 166.5 million outstanding shares for $233 million market cap, per LSEG data</p><p>** All eight brokerages covering the stock rate it \"buy\" or higher; median PT $5 - data compiled by LSEG</p><p>** As of last close, TNYA stock down 4.9% YTD</p><p> (Reporting by Arasu Kannagi Basil in Bengaluru)</p><p> ((ArasuKannagi.Basil@thomsonreuters.com;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"PIPR","symbol_name":"派杰投资","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251211:nL6N3XH135:1","article_id":"2590544071","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2590544071","pubTimestamp":1765491937,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BUZZ-Tenaya Therapeutics slides after launching stock offering** Drug developer Tenaya Therapeutics' TNYA.O shares slide 12.5% to $1.19 in extended trading** TNYA unveils public offering of common stock and warrants; size not disclosed** Leerink Partners and Piper Sandler are joint bookrunning managers for offering ** Separately, TNYA announces data from early trial for experimental gene therapy in rare heart condition** TNYA has 166.5 million outstanding shares for $233 million market cap, per LSEG data** All eight brokerages covering the stock rate it \"buy\" or higher; median PT $5 - data compiled by LSEG** As of last close, TNYA stock down 4.9% YTD  ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"PIPR":"派杰投资","BK4539":"次新股","BK4139":"生物科技","TNYA":"Tenaya Therapeutics Inc","BK4127":"投资银行业与经纪业","MNSH":"MNSN HLDGS INC.","BK4207":"综合性银行"},"translate_title":"BUZZ-Tenaya Therapeutics在启动股票发行后股价下滑","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"PIPR":0.9,"MNSH":0.9,"TNYA":0.9},"content_text":"BUZZ-Tenaya Therapeutics slides after launching stock offering** Drug developer Tenaya Therapeutics' TNYA.O shares slide 12.5% to $1.19 in extended trading** TNYA unveils public offering of common stock and warrants; size not disclosed** Leerink Partners and Piper Sandler are joint bookrunning managers for offering ** Separately, TNYA announces data from early trial for experimental gene therapy in rare heart condition** TNYA has 166.5 million outstanding shares for $233 million market cap, per LSEG data** All eight brokerages covering the stock rate it \"buy\" or higher; median PT $5 - data compiled by LSEG** As of last close, TNYA stock down 4.9% YTD (Reporting by Arasu Kannagi Basil in Bengaluru) ((ArasuKannagi.Basil@thomsonreuters.com;))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"shareholding","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2590544071","isCrawlerRequest":true}